Authors:
WALSH TJ
YELDANDI V
MCEVOY M
GONZALEZ C
CHANOCK S
FREIFELD A
SEIBEL NI
WHITCOMB PO
JAROSINSKI P
BOSWELL G
BEKERSKY I
ALAK A
BUELL D
BARRET J
WILSON W
Citation: Tj. Walsh et al., SAFETY, TOLERANCE, AND PHARMACOKINETICS OF A SMALL UNILAMELLAR LIPOSOMAL FORMULATION OF AMPHOTERICIN-B (AMBISOME) IN NEUTROPENIC PATIENTS, Antimicrobial agents and chemotherapy, 42(9), 1998, pp. 2391-2398
Authors:
BOSWELL GW
BEKERSKY I
BUELL D
HILES R
WALSH TJ
Citation: Gw. Boswell et al., TOXICOLOGICAL PROFILE AND PHARMACOKINETICS OF A UNILAMELLAR LIPOSOMALVESICLE FORMULATION OF AMPHOTERICIN-B IN RATS, Antimicrobial agents and chemotherapy, 42(2), 1998, pp. 263-268
Authors:
NASH RA
ANTIN J
KARANES C
FAY J
AVALOS B
YEAGER AM
PRZEPIORKA D
DAVIES S
PETERSEN F
BUELL D
FITZSIMMONS W
BARTELS P
HANSEN J
ANASETTI C
STORB R
RATANATHARATHORN V
Citation: Ra. Nash et al., PHASE-III STUDY COMPARING TACROLIMUS (FK506) WITH CYCLOSPORINE (CSP) FOR PROPHYLAXIS OF ACUTE GRAFT-VERSUS-HOST DISEASE (GVHD) AFTER MARROWTRANSPLANTATION FROM UNRELATED DONORS, Blood, 90(10), 1997, pp. 2499-2499
Citation: W. Luk et D. Buell, SPECIAL ISSUE ON FIELD-PROGRAMMABLE GATE ARRAYS - INTRODUCTION, Journal of VLSI signal processing systems for signal, image, and video technology, 12(1), 1996, pp. 5-5
Citation: M. Schwartz et al., FK-506 IN LIVER-TRANSPLANTATION - CORRELATION OF WHOLE-BLOOD LEVELS WITH EFFICACY AND TOXICITY, Transplantation proceedings, 27(1), 1995, pp. 1107-1107
Authors:
BUSUTTIL RW
MCDIARMID S
KLINTMALM GB
GOLDSTEIN R
MILLER CM
SCHWARTZ M
SHAW BW
ROBERTS JP
HEBERT MF
ESQUIVEL CO
NAKAZATO P
WIESNER RH
KROM RAF
KALAYOGLU M
DALESSANDRO AM
MARSH JW
PETERS MG
BURDICK J
KLEIN A
LEWIS WD
JENKINS R
THISTLETHWAITE JR
EMOND JC
JUSKO WJ
DAMBROSIO R
BUELL D
FITZSIMMONS WE
Citation: Rw. Busuttil et al., A COMPARISON OF TACROLIMUS (FK-506) AND CYCLOSPORINE FOR IMMUNOSUPPRESSION IN LIVER-TRANSPLANTATION, The New England journal of medicine, 331(17), 1994, pp. 1110-1115